Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SaluDesign was a medical device company dedicated to advancing the field of cardiac surgery through the development of innovative annuloplasty technologies. The company specialized in creating flexible and adjustable rings designed for the repair of mitral and tricuspid valves, addressing conditions such as valvular regurgitation. Its technology was engineered to provide surgeons with greater precision during valve remodeling procedures, ultimately aiming to restore proper valve function and improve patient outcomes. In 2004, SaluDesign was acquired by Edwards Lifesciences, a global leader in structural heart disease and critical care monitoring. The acquisition integrated SaluDesign's specialized ring designs into the Edwards heart valve repair portfolio, further solidifying their market position in cardiovascular interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SaluDesign.